41![REPRINT FROM APRIL 27, 2015 CLINICAL NEWS CLINICAL STATUS Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn. REPRINT FROM APRIL 27, 2015 CLINICAL NEWS CLINICAL STATUS Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn.](https://www.pdfsearch.io/img/bf7e5b3d60cfba0900bb01f5300ded2e.jpg) | Add to Reading ListSource URL: www.pvct.comLanguage: English - Date: 2015-05-04 14:21:06
|
---|
42![EFP
Product
Surface
Cleaners INCI CAS# EFP
Product
Surface
Cleaners INCI CAS#](https://www.pdfsearch.io/img/ebdaa2548e394b42685513d9bf942baf.jpg) | Add to Reading ListSource URL: www.ecos.comLanguage: English - Date: 2014-09-09 12:19:30
|
---|
43![Medication Guide JANUMET® (JAN-you-met) (sitagliptin and metformin hydrochloride) Tablets Read this Medication Guide carefully before you start taking JANUMET and each time you get a refill. There may be new information Medication Guide JANUMET® (JAN-you-met) (sitagliptin and metformin hydrochloride) Tablets Read this Medication Guide carefully before you start taking JANUMET and each time you get a refill. There may be new information](https://www.pdfsearch.io/img/3feffb363ab11e2cafd874fa2ac2ed82.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2015-03-26 19:23:33
|
---|
44![REPRINT FROM APRIL 27, 2015 CLINICAL NEWS CLINICAL STATUS Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn. REPRINT FROM APRIL 27, 2015 CLINICAL NEWS CLINICAL STATUS Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn.](https://www.pdfsearch.io/img/6d6df8639f4e8fb88c7a946a93830541.jpg) | Add to Reading ListSource URL: www.pvct.comLanguage: English - Date: 2015-05-04 14:21:06
|
---|
45![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. ® HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. ®](https://www.pdfsearch.io/img/cfe7c44ffe465367e27d36896a7eca11.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2015-03-26 19:23:33
|
---|
46![Preferred Drug List forList is subject to change prior to Jan. 1, 2015) Allergy/Cough & Cold Tier 1 Preferred Drug List forList is subject to change prior to Jan. 1, 2015) Allergy/Cough & Cold Tier 1](https://www.pdfsearch.io/img/5c8a1c76841659cbf4c3c51685f1ba61.jpg) | Add to Reading ListSource URL: www.bcbst.comLanguage: English - Date: 2014-08-29 13:50:41
|
---|
47![Essential Drug List forList is subject to change prior to Jan. 1, 2015) Allergy/Cough & Cold Tier 1 Essential Drug List forList is subject to change prior to Jan. 1, 2015) Allergy/Cough & Cold Tier 1](https://www.pdfsearch.io/img/84302656b6fa0b70b0a0d52fa2aa8980.jpg) | Add to Reading ListSource URL: www.bcbst.comLanguage: English - Date: 2014-08-29 13:50:41
|
---|
48![International Journal of Chemical and Natural Science International Journal of Chemical and Natural Science](https://www.pdfsearch.io/img/472e9281fa68958ed566364e2f2175b5.jpg) | Add to Reading ListSource URL: ijps.aizeonpublishers.netLanguage: English - Date: 2015-04-30 14:46:42
|
---|
49![Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir over 48 weeks in treatm Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir over 48 weeks in treatm](https://www.pdfsearch.io/img/a9af672b1fabab8ed0cdaa292eb562a0.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:24
|
---|
50![ENB 10th AnniversaryPIC-9 #2 Earth ENB 10th AnniversaryPIC-9 #2 Earth](https://www.pdfsearch.io/img/52cff0a02e236620e12149e17f0093fb.jpg) | Add to Reading ListSource URL: www.iisd.caLanguage: English - Date: 2002-09-30 16:40:05
|
---|